Assessment of the Efficacy of FOSFOMYCIN in Patients With Bacterial Infection

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01173575

Enrollment

209

Registered

2010-08-02

Start date

2010-08-31

Completion date

2016-12-31

Last updated

2019-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bacterial Infection

Brief summary

This project aims to assess the clinical and microbiological efficacy of fosfomycin(FOM) in patients with bacterial infection. Primary objective: • To assess clinical and microbiological efficacy of FOM in patients with bacterial infection. Secondary objectives: * To determine the rate and severity of unexpected adverse events. * To determine the mean duration of therapy with FOM in patients with bacterial infection. Study design: Multi-center, non-interventional study

Detailed description

Please note that InfectoPharm Arzneimittel und Consilium GmbH has taken over sponsor responsibilities for all German sites of this clinical trial with Jannuary 2016 from J&P MEDICAL RESEARCH LTD.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patients with bacterial infection receiving FOM for clinical purposes will be included into the analysis.

Exclusion criteria

Countries

Austria, Germany

Outcome results